Cargando…
Toward reaching hepatitis B goals: hepatitis B epidemiology and the impact of two decades of vaccination, Georgia, 2021
BACKGROUND: Georgia has adopted the World Health Organization European Region’s and global goals to eliminate viral hepatitis. A nationwide serosurvey among adults in 2015 showed 2.9% prevalence for hepatitis B virus (HBV) surface antigen (HBsAg) and 25.9% for antibodies against HBV core antigen (an...
Autores principales: | Khetsuriani, Nino, Gamkrelidze, Amiran, Shadaker, Shaun, Tsereteli, Maia, Alkhazashvili, Maia, Chitadze, Nazibrola, Tskhomelidze, Irina, Gvinjilia, Lia, Averhoff, Francisco, Cloherty, Gavin, An, Qian, Chakhunashvili, Giorgi, Drobeniuc, Jan, Imnadze, Paata, Zakhashvili, Khatuna, Armstrong, Paige A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Centre for Disease Prevention and Control (ECDC)
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375835/ https://www.ncbi.nlm.nih.gov/pubmed/37498531 http://dx.doi.org/10.2807/1560-7917.ES.2023.28.30.2200837 |
Ejemplares similares
-
Risk factors and genotype distribution of hepatitis C virus in Georgia: A nationwide population-based survey
por: Baliashvili, Davit, et al.
Publicado: (2022) -
Hepatitis C prevalence and risk factors in Georgia, 2015: setting a baseline for elimination
por: Hagan, Liesl M., et al.
Publicado: (2019) -
The Role of Screening and Treatment in National Progress Toward Hepatitis C Elimination — Georgia, 2015–2016
por: Nasrullah, Muazzam, et al.
Publicado: (2017) -
Insights from a national survey in 2021 and from modelling on progress towards hepatitis C virus elimination in the country of Georgia since 2015
por: Walker, Josephine G., et al.
Publicado: (2023) -
Progress in Testing for and Treatment of Hepatitis C Virus Infection Among Persons Who Inject Drugs — Georgia, 2018
por: Stvilia, Ketevan, et al.
Publicado: (2019)